1,181.87 USD
↘ 6.71 (0.57%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,182.55
↗ 0.68 (0.06%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1,182.55
↗ 0.68 (0.06%)
Market: CLOSED
Shares of Eli Lilly & Co. (LLY) are trading at $1,181.94. Both sides of the analysis agree: technicals flash "Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 13, 2026.
Open?$1,180.11
High?$1,196.29
Low?$1,166.01
Prev. Close?$1,188.58
Volume?2.1M
Avg. Volume?3.3M
VWAP?$1,186.44
Rel. Volume?0.63x
Bid / Ask
Bid?$1,180.10 × 120
Ask?$1,194.00 × 40
Spread?$13.90
Midpoint?$1,187.05
Valuation & Ratios
Market Cap?1059.9B
Shares Out?941.7M
Float?848.6M
Float %?90.1%
P/E Ratio?41.93
P/B Ratio?33.97
EPS?$28.35
Dividend?0.53%
Ex-Dividend?2026-08-14
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1059.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?84
Piotroski F-Score?6/9Mixed
Altman Z-Score?9.50Safe
Confidence?80%High
Short InterestLow
Short % of Float?1.10%Low
Short Interest?9.4M
Days to Cover?2.6
Free Float848.6M
Avg Daily Volume3.6M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?41.9PRICEY▾
Peers20
S&P17
P/B?33.97HIGH▾
Peers10
S&P3
P/S?14.67HIGH▾
Peers20
S&P3
P/FCF?89.7PRICEY▾
Peers10
S&P3
EV/EBITDA?30.3HIGH▾
Peers20
S&P10
EV/Sales?15.20HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?81.0%STRONG▾
Peers78
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$1098.0B
Fundamentals ratios updated end of day